PRESSURE BIOSCIENCES INC (18)

Browse by Contract Category

Contracts

2021 Equity Incentive Plan (Filed With SEC on April 5, 2022)
Form of Convertible Note Currently Outstanding (Filed With SEC on April 5, 2022)
Description of securities registered under Section 12 of the Exchange Act of 1934 (Filed With SEC on April 5, 2022)
Form of Convertible Note Currently Outstanding (Filed With SEC on April 5, 2022)
Form of Warrant Held by Convertible Note Holders (Filed With SEC on April 5, 2022)
Description of securities registered under Section 12 of the Exchange Act of 1934 (Filed With SEC on April 15, 2021)
Fourth Amendment to Binding Acquisition Letter of Intent by and between Pressure BioSciences, Inc. and Cannaworx, Inc., dated December 30, 2020 (Filed With SEC on December 31, 2020)
Third Amendment to Binding Acquisition Letter of Intent, Dated November 6, 2020 (Filed With SEC on November 6, 2020)
Second amendment to binding acquisition letter of intent, dated October 5, 2020 (Filed With SEC on October 9, 2020)
Security Agreement, dated June 25, 2020, by and between Pressure BioSciences, Inc. and the U.S. Small Business Administration (Filed With SEC on August 14, 2020)
Economic Injury Disaster Loan Note, dated June 25, 2020, issued to the U.S. Small Business Administration (Filed With SEC on August 14, 2020)
First Amendment to Binding Letter of Intent by and between Pressure BioSciences, Inc. and Cannaworx, Inc., dated July 6, 2020 (Filed With SEC on August 14, 2020)
Binding Letter of Intent by and between Pressure BioSciences, Inc. and Cannaworx, Inc., dated April 29, 2020 (Filed With SEC on August 14, 2020)
10% Senior Secured Convertible Promissory Note, dated December 20, 2019 (Filed With SEC on December 30, 2019)
Registration Rights Agreement, dated December 20, 2019 (Filed With SEC on December 30, 2019)
General Security Agreement, dated December 20, 2019 (Filed With SEC on December 30, 2019)
Common Stock Purchase Warrant, dated December 20, 2019 (Filed With SEC on December 30, 2019)
Securities Purchase Agreement, dated December 20, 2019 (Filed With SEC on December 30, 2019)